Intelligent Bio Solutions Inc. · NASDAQ:INBS
Intelligent Bio Solutions — Glucose Biosensor Systems (Greater China) Holdings — Reg A Offering (October 2018)
21 slides from Intelligent Bio Solutions's offering presentation, October 2018
Slide 1: Investor Presentation October 2018
INVESTOR PRESENTATION OCTOBER 2018
Slide 2: Legal Disclaimer
LEGAL DISCLAIMER This presentation is for informational purposes . Any offer of the Company’s securities will be made solely by means of the offering circular contained in a qualified offering statement . An offering statement on Form 1 - A relating to the Company’s securities has been filed with th
Slide 3: Offering Summary
OFFERING SUMMARY Issuer/Ticker Glucose Biosensor Systems (Greater China) Holdings Inc. Type of Offering Initial Public Offering Symbol GBSG Pre - Offering Common Stock Outstanding 8,250,000 Shares - Minimum Offering $9,000,000 - Maximum Offering $25,000,000 Share Price $12.00 Use of Proceeds • Devel
Slide 4: The Company
THE COMPANY Delaware corporation based in New York, GBSG holds the exclusive regional license of the Glucose Biosensor System for the Greater China Region . The biosensor uses saliva, not blood , to measure glucose . GBSG believes that the biosensor fabrication method will allow for printing at high
Slide 5: Board of Directors
BOARD OF DIRECTORS Dr. Jean Claude Becker M.D. COO, Executive VP & Director • A widely published, global researcher with expertise in developing and positioning innovative products . • Former Group Director of Global Clinical Research in Immunology at Bristol - Myers Squibb, and senior roles at Sand
Slide 6: Diabetes - A Global Epidemic
DIABETES - A GLOBAL EPIDEMIC 1 in 11 adults had diabetes 2017 1 in 10 adults will have diabetes 2045 2017 2045 People with diabetes worldwide 425M 629M IDF Diabetes Atlas 2017 10.9% of Chinese adults have diabetes 114.4m patients 1/4 of the world’s diabetic population That’s DIABETES IN CHINA
Slide 7: Importance of Glucose Monitoring
IMPORTANCE OF GLUCOSE MONITORING Glucose monitoring determines glucose levels and identifies if the patient is within a specified target range . It lets patients understand the cause and effect relationship between variables such as diet, exercise, stress and medication . The patients who control th
Slide 8: Traditional Blood Glucose Measurement Method - The Problem
TRADITIONAL BLOOD GLUCOSE MEASUREMENT METHOD THE PROBLEM Invasive finger stick devices must be used several times a day Lancing of the finger to draw blood can be painful and can lead to risk of infection The blood sample is then placed on a disposable test strip that is inserted into a blood glucos
Slide 9: The Innovation and Opportunity
THE INNOVATION AND OPPORTUNITY Saliva based glucose monitoring - revolutionizing diabetes management The non - invasive, pain - free and easy - to - use Glucose Biosensor System Bring the Saliva Glucose Biosensor in contact with saliva Glucose level reading is displayed on a smart device View result
Slide 10: The Biosensor Unit: Technology Evolution with Patent Protected Sales to 2033
THE BIOSENSOR UNIT Technology Evolution with Patent Protected Sales to 2033 Professor Paul Dastoor and University of Newcastle team began research into conducting polymers Priority Research Centre for Organic Electronics established in the School of Physics, University of Newcastle OTFT - based sali
Slide 11: The Biosensor Unit: Organic Thin Film Transistor (OTFT)
THE BIOSENSOR UNIT Organic Thin Film Transistor (OTFT) Glucose concentrations are considerably lower in saliva compared to capillary blood glucose Detection sensitivity becomes of primary importance The biosensor exhibits a linear glucose response at concentrations 100 times lower than commercial gl
Slide 12: GBS - System Architecture
GBS - SYSTEM ARCHITECTURE Cloud data processing Two - way data flow Improved glucose management Better health outcomes Image Placeholder Historic glucose level comparison
Slide 13: Non-Invasive Sampling, Higher User Compliance
NON - INVASIVE SAMPLING HIGHER USER COMPLIANCE IMPROVED PATIENT GLYCEMIC CONTROL → → NORMOGLYCEMIA IMPROVED HEALTH OUTCOMES COST SAVINGS → → INCREASED MONITORING = HEALTHCARE SAVINGS
Slide 14: Regulatory Strategy and Launch
. REGULATORY STRATEGY AND LAUNCH REGULATORY STRATEGY MEDICAL & CLINICAL AFFAIRS MARKET ENTRY STRATEGY 2 3 1 Commenced Commenced January 2019 • Commence process of creating awareness with : • Patients • Practitioners • Caregivers • ‘Celebrity’ patients • Align with Key Opinion Leader physicians . • E
Slide 15: Overview of License Agreement
OVERVIEW OF LICENSE AGREEMENT 1. Promote, market and commercialize the glucose biosensor in the Greater China Region (GCR) . 2. Provide customer support on the glucose biosensor in the GCR . 3. Sell the licensed products in the GCR . 4. First refusal for other diagnostics . 1. Conduct clinical studi
Slide 16: Competition
COMPETITION Requires invasive sampling and finger prick calibration Slower glucose level changes Continuous Glucose Monitoring
Slide 17: Incremental Innovation in Last Years
INCREMENTAL INNOVATION IN LAST 40 YEARS Based on Same Traditional Technology MyDario OneDrop Image Placeholder
Slide 18: Future Competition
FUTURE COMPETITION Lasers Breath - based Measurements Eye - based Technologies Tear Sample Skin Detection Ear Lobe Sensors or Ear Canals
Slide 19: Market Overview
MARKET OVERVIEW What we know: In China, there are 114 million diabetic patients Assume, 1% of these patients use a glucose biosensor strip 3x per day 1.2bn strips…per annum x x =
Slide 20: Investment Highlights
20 INVESTMENT HIGHLIGHTS Key Points Not incremental but exponential innovation – non - invasive disruptive technology . Eliminates the need for “finger pricking” multiple times daily . Higher patient compliance leads to improved glycemic control, better healthcare outcomes for patients with diabetes
Slide 21: Frost & Sullivan quote on salivary glucose detection
The development of a low - cost salivary glucose detection method based on organic electronic circuitry would represent a major advance in diabetes management. Frost & Sullivan California - based research and consulting firm
Glucose Biosensor Systems (Greater China) Holdings — Reg A Offering (October 2018) on 6ix